Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for mesenteric traction syndrome during radical gastrectomy
ChiCTR1800014506Phase 4Not yet recruiting
- Sponsor
- Zhenjiang First People's Hospital
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in Mesenteric traction syndrome (MTS) (3 arms), sponsored by Zhenjiang First People's Hospital. Primary endpoints: Concentration of plasma 6-keto-PGF1α, Incidence rate of face flushing and 3 more. Planned start Feb 2018; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Mesenteric traction syndrome (MTS)
Beyond the preview
Go deeper on ChiCTR1800014506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014506.